RNA sequencing identifies novel markers of non-small cell lung cancer

Lung Cancer

Volumn 84, Issue 3, 2014, Pages 229-235

  Han, Seon Sook ^a   Kim, Woo Jin ^a   Hong, Yoonki ^a   Hong, Seok Ho ^a   Lee, Seung Joon ^a   Ryu, Dong Ryeol ^a   Lee, Wonho ^a   Cho, Yo Han ^a   Lee, Seungkoo ^a   Ryu, Young Joon ^a   Won, Jun Yeon ^a   Rhee, Hwanseok ^b   Park, Jung Hoon ^b   Jang, Se Jin ^c   Lee, Jae Seung ^c   Choi, Chang Min ^c   Lee, Jae Cheol ^c   Lee, Sang Do ^c   Oh, Yeon Mok ^c  

^a Kangwon National University   (South Korea)

^b Macrogen Inc   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Carcinoma, Non small cell lung; Gene expression profiling; Sequence analysis, RNA; Transcriptome

Indexed keywords

CAVEOLIN 1; CELLULAR RETINOIC ACID BINDING PROTEIN 2; CHROMOBOX HOMOLOG 3; CLAUDIN 18; CONNEXIN 26; CYTOKERATIN 15; CYTOKERATIN 16; CYTOKERATIN 17; CYTOKERATIN 5; DESMOPLAKIN; GLUTATHIONE PEROXIDASE 2; GLYCOSYLATED HEMOGLOBIN; INDOMETHYLAMINE N METHYLTRANSFERASE; INTERSTITIAL COLLAGENASE; KERATIN 6A; OSTEOPONTIN; PLAKOPHILLIN 1; S100A2 PROTEIN; SURFACTANT PROTEIN A1; SURFACTANT PROTEIN A2; SURFACTANT PROTEIN C; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTOME; TRANSMEMBRANE PROTEASE SERINE 4; TROPONIN C; TUMOR MARKER; UNCLASSIFIED DRUG; UROPLAKIN 3B; WNT INHIBITORY FACTOR 1; CBX3 PROTEIN, HUMAN; NONHISTONE PROTEIN; RETINOIC ACID BINDING PROTEIN II, CELLULAR; RETINOIC ACID RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RNA SEQUENCE; UPREGULATION; AGED; BIOSYNTHESIS; GENETICS; HIGH THROUGHPUT SEQUENCING; LUNG TUMOR; MIDDLE AGED; NON SMALL CELL LUNG CANCER; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TISSUE MICROARRAY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOMAL PROTEINS, NON-HISTONE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, RETINOIC ACID; SEQUENCE ANALYSIS, RNA; TISSUE ARRAY ANALYSIS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84901949142     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.03.018     Document Type: Article

References (36)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
2. Alberg A.J., Ford J.G., Samet J.M., American College of Chest Physicians Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:29S-55S.
3. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
4. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. The sequence of the human genome. Science 2001, 291:1304-1351.
5. Agullo-Ortuno M.T., Lopez-Rios F., Paz-Ares L. Lung cancer genomic signatures. J Thorac Oncol 2010, 5:1673-1691.
6. Woenckhaus M., Klein-Hitpass L., Grepmeier U., Merk J., Pfeifer M., Wild P., et al. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers. J Pathol 2006, 210:192-204.
7. Spira A., Beane J.E., Shah V., Steiling K., Liu G., Schembri F., et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007, 13:361-366.
8. Landi M.T., Dracheva T., Rotunno M., Figueroa J.D., Liu H., Dasgupta A., et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS ONE 2008, 3:e1651.
9. Boelens M.C., van den Berg A., Fehrmann R.S., Geerlings M., de Jong W.K., te Meerman G.J., et al. Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer. J Pathol 2009, 218:182-191.
10. Tuch B.B., Laborde R.R., Xu X., Gu J., Chung C.B., Monighetti C.K., et al. Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations. PLoS ONE 2010, 5:e9317.
11. Wang Y., Li Y., Liu S., Shen W., Jiang B., Xu X., et al. Study on the dynamic behavior of a DNA microarray. J Nanosci Nanotechnol 2005, 5:1249-1255.
12. Casneuf T., Van de Peer Y., Huber W. In situ analysis of cross-hybridisation on microarrays and the inference of expression correlation. BMC Bioinformatics 2007, 8:461.
13. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458:719-724.
14. Oshlack A., Robinson M.D., Young M.D. From RNA-seq reads to differential expression results. Genome Biol 2010, 11:220.
15. Cancer Genome Atlas Research Network Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012, 489:519-525.
16. Seo J.S., Ju Y.S., Lee W.C., Shin J.Y., Lee J.K., Bleazard T., et al. The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res 2012, 22:2109-2119.
17. Trapnell C., Pachter L., Salzberg S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25:1105-1111.
18. Trapnell C., Williams B.A., Pertea G., Mortazavi A., Kwan G., van Baren M.J., et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010, 28:511-515.
19. Weber G.F., Lett G.S., Haubein N.C. Categorical meta-analysis of osteopontin as a clinical cancer marker. Oncol Rep 2011, 25:433-441.
20. Zhao B., Sun T., Meng F., Qu A., Li C., Shen H., et al. Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer. J Cancer Res Clin Oncol 2011, 137:1061-1070.
21. Camilo R., Capelozzi V.L., Siqueira S.A., Del Carlo Bernardi F. Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas. Hum Pathol 2006, 37:542-546.
22. Chen Y., Cui T., Yang L., Mireskandari M., Knoesel T., Zhang Q., et al. The diagnostic value of cytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer. Oncology 2011, 80:333-340.
23. Campioni M., Ambrogi V., Pompeo E., Citro G., Castelli M., Spugnini E.P., et al. Identification of genes down-regulated during lung cancer progression: a cDNA array study. J Exp Clin Cancer Res 2008, 27:38.
24. Cai Y.R., Zhang H.Q., Qu Y., Mu J., Zhao D., Zhou L.J., et al. Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation. Oncol Rep 2011, 26:877-885.
25. Costa V., Aprile M., Esposito R., Ciccodicola A. RNA-Seq and human complex diseases: recent accomplishments and future perspectives. Eur J Hum Genet 2013, 21:134-142.
26. Takanashi M., Oikawa K., Fujita K., Kudo M., Kinoshita M., Kuroda M. Heterochromatin protein 1gamma epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cancers. Am J Pathol 2009, 174:309-316.
27. Ruan J., Ouyang H., Amaya M.F., Ravichandran M., Loppnau P., Min J., et al. Structural basis of the chromodomain of Cbx3 bound to methylated peptides from histone h1 and G9a. PLOS ONE 2012, 7:e35376.
28. Saini V., Hose C.D., Monks A., Nagashima K., Han B., Newton D.L., et al. Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma. PLOS ONE 2012, 7:e41401.
29. Budhu A.S., Noy N. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol Cell Biol 2002, 22:2632-2641.
30. Gudas L.J. Emerging roles for retinoids in regeneration and differentiation in normal and disease states. Biochim Biophys Acta 2012, 1821:213-221.
31. Schug T.T., Berry D.C., Shaw N.S., Travis S.N., Noy N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 2007, 129:723-733.
32. Geiger T., Madden S.F., Gallagher W.M., Cox J., Mann M. Proteomic portrait of human breast cancer progression identifies novel prognostic markers. Cancer Res 2012, 72:2428-2439.
33. Toyama A., Suzuki A., Shimada T., Aoki C., Aoki Y., Umino Y., et al. Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers. Cancer Sci 2012, 103:747-755.
34. Calmon M.F., Rodriques R.V., Kaneto C.M., Moura R.P., Silva S.D., Mota L.D., et al. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia 2009, 11:1329-1339.
35. Wilkerson M.D., Yin X., Hoadley K.A., Liu Y., Hayward M.C., Cabanski C.R., et al. Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types. Clin Cancer Res 2010, 16:4864-4875.
36. Mwenifumbo J.C., Marra M.A. Cancer genome-sequencing study design. Nat Rev Genet 2013, 14:321-332.